Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CLEC-1 inhibitors(C-type lectin domain family 1 member A inhibitors), Mitophagy inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Arctic TherapeuticsStartup |
Active Organization Arctic TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 2 | US | Arctic TherapeuticsStartup | - |
Inflammatory Bowel Diseases | Phase 2 | US | Arctic TherapeuticsStartup | - |
Multiple Sclerosis | Phase 2 | US | Arctic TherapeuticsStartup | - |
Parkinson Disease | Phase 2 | US | Arctic TherapeuticsStartup | - |
Rheumatoid Arthritis | Phase 2 | US | Arctic TherapeuticsStartup | - |
Systemic Lupus Erythematosus | Phase 2 | US | Arctic TherapeuticsStartup | - |